Destiny Pharma (DEST)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

17.17p
   
  • Change Today:
    -4.33p
  • 52 Week High: 82.00
  • 52 Week Low: 13.20
  • Currency: UK Pounds
  • Shares Issued: 95.31m
  • Volume: 6,528,828
  • Market Cap: £16.36m
  • RiskGrade: 410

Latest Deals

Traded Action Notifier PriceAmountValue
29-Sep-23 Transfer To William Love 0.000p 2,300,000 £0.00
26-May-23 Buy Nick (Philip) Rodgers 30.19p 20,000 £6,037.96
25-May-23 Buy Aled Williams 31.00p 50,000 £15,500.00
25-May-23 Buy Aled Williams 31.00p 50,000 £15,500.00
25-May-23 Buy Debra Barker 33.00p 20,000 £6,600.00

Largest Deals (365 days)

Traded Action Notifier PriceAmountValue
25-May-23 Buy Aled Williams 31.00p 50,000 £15,500.00
25-May-23 Buy Aled Williams 31.00p 50,000 £15,500.00
25-May-23 Buy Nick (Philip) Rodgers 31.00p 49,477 £15,337.87
25-May-23 Buy Debra Barker 33.00p 20,000 £6,600.00
26-May-23 Buy Nick (Philip) Rodgers 30.19p 20,000 £6,037.96

Director Shareholdings

Notifier Holding Value*
William Love 6,509,500 £1,117,464
Nigel Rudd 1,229,900 £211,133
Debra Barker 88,461 £15,186
Aled Williams 50,000 £8,583

Major Shareholders

Notifier** Holding Value*
The Wade Family 5,946,500 £1,020,816
Hargreave Hale Limited 4,877,070 £837,230
Rosetta Capital V GP Limited 3,089,971 £530,445
Canaccord Genuity Group Inc 2,995,690 £514,260
Nigel Rudd 1,921,716 £329,895
A&B (HK) Company Ltd 1,910,828 £328,026
CMS Medical Venture Investment Limited 1,910,828 £328,026
Andrew Cohen 1,858,500 £319,042
Rock (Nominees) Ltd 1,542,500 £264,796

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Destiny Pharma Market Data

Currency UK Pounds
Share Price 17.17p
Change Today -4.33p
% Change -20.16 %
52 Week High 82.00
52 Week Low 13.20
Volume 6,528,828
Shares Issued 95.31m
Market Cap £16.36m
RiskGrade 410

Destiny Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
33.11% below the market average33.11% below the market average33.11% below the market average33.11% below the market average33.11% below the market average
58.49% below the sector average58.49% below the sector average58.49% below the sector average58.49% below the sector average58.49% below the sector average
Price Trend
78.21% below the market average78.21% below the market average78.21% below the market average78.21% below the market average78.21% below the market average
22.81% below the sector average22.81% below the sector average22.81% below the sector average22.81% below the sector average22.81% below the sector average
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 0
Buy 1
Neutral 0
Sell 0
Strong Sell 0
Total 1
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Destiny Pharma Dividends

No dividends found

Trades for 25-Apr-2024

Time Volume / Share Price
13:48 8,161 @ 17.01p
13:47 31,025 @ 17.03p
13:47 10,500 @ 17.15p
13:41 10,000 @ 17.13p
13:39 2,000 @ 17.41p

Destiny Pharma Key Personnel

CEO Chris Tovey

Top of Page